PRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts by David G Molleví et al.
BioMed CentralMolecular Cancer
ssOpen AcceShort communication
PRL-3 overexpression in epithelial cells is induced by surrounding 
stromal fibroblasts
David G Molleví*1, Alvaro Aytes2, Mireia Berdiel1, Laura Padullés1, 
Maria Martínez-Iniesta1, Xavier Sanjuan3, Ramon Salazar4 and 
Alberto Villanueva1
Address: 1Translational Research Laboratory, Institut Català d'Oncologia, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 
L'Hospitalet de Llobregat, Barcelona, Spain, 2Herbert Irving Comprehensive Cancer Center, Columbia University, USA, 3Department of Pathology, 
Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain and 
4Department of Medical Oncology, Institut Català d'Oncologia, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08907 L'Hospitalet de 
Llobregat, Barcelona, Spain
Email: David G Molleví* - dgmollevi@iconcologia.net; Alvaro Aytes - alvaroaytesm@gmail.com; Mireia Berdiel - mberdiel@iconcologia.net; 
Laura Padullés - lpadulles@iconcologia.net; Maria Martínez-Iniesta - mmi@iconcologia.net; Xavier Sanjuan - xsanjuan@bellvitgehospital.cat; 
Ramon Salazar - ramonsalazar@iconcologia.net; Alberto Villanueva - avillanueva@iconcologia.net
* Corresponding author    
Abstract
We isolate and culture carcinoma-associated fibroblasts (CAFs) from primary tumour (CAFpt),
CAFs from corresponding synchronous liver metastasis (CAFlm) as well as normal colonic
fibroblasts (NCF) from the same patient. From these cultures, conditioned media (CM) was
obtained. Culture of a wide panel of colorectal and pancreatic cell lines in CM from CAFlm resulted
in overexpression of mRNA PRL-3 and higher overexpression in CAFs than in non-activated
fibroblasts. Moreover PRL-3 mRNA expression correlates with expression of α-SMA and
deposition of collagen fibrils in the stroma. We demonstrate that products secreted by CAFs
trigger PRL-3 overexpression in cancer cells. Identification of these factors may contribute to new
stroma-targeted therapies for desmoplastic tumours.
Introduction
In many epithelial tumours inclouding colorectal, the rel-
evance of PRL-3 phosphatase to the tumorigenic process
of distant dissemination is well documented [1-5]. While
some manuscripts adress the downstream pathways in
which PRL-3 could influence the processes of migration
and invasion [6,7], there is a complete lack of knowledge
of the events upstream PRL-3.
In colorectal tumorigenesis, PRL-3 was identified as a
molecule consistently overexpressed in hepatic metas-
tases. These tumours are characterised by a strong desmo-
plastic reaction, consisting predominantly of carcinoma-
associated fibroblasts (CAFs) and collagen I fibrils, which
are also a hallmark of colorectal adenocarcinomas (CRC).
In the case of primary tumours, the desmoplastic reaction
contributes to the spreading of tumoral epithelial cells.
But for liver metastasis, the biological significance of
desmoplasia is still unclear. Some authors consider
desmoplasia as a wall to keep tumour cells under control.
If desmoplasia is a mechanism of walling off or is a reac-
tion to promote spreading of epithelial cells will depend
probably on the composition of extracellular matrix
(ECM) and cells responsible for the deposition of ECM
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A: normalised PRL-3 mRNA expression of colorectal (HCT-116, CaCo2, HT-29, DLD-1, LoVo, KM12C, KM12SM, SW480 and MH35-D2) and pancreatic c ll lines (NP18-MP2 and NP18-MH5) cultured in DMEMF12 + 10% FBS or conditioned medium (CM) obtained from carcinoma-as ociated fibroblasts derived from a liv r metastasis (CAFlm)Figure 1
A: normalised PRL-3 mRNA expression of colorectal (HCT-116, CaCo2, HT-29, DLD-1, LoVo, KM12C, 
KM12SM, SW480 and MH35-D2) and pancreatic cell lines (NP18-MP2 and NP18-MH5) cultured in DMEMF12 
+ 10% FBS or conditioned medium (CM) obtained from carcinoma-associated fibroblasts derived from a liver 
metastasis (CAFlm). Total RNA were retrieved from cellular pellets using TrizOL Reagent method. cDNA was obtained 
using recombinant ribonuclease inhibitor RNAse OUT and M-MLV retrotranscriptase. Quantitative real-time RT-PCR analyses 
were performed using the Light-Cycler 2.0 Roche System and LightCycler FastStart DNA Master SyBR Green I kit (Roche). 
For normalisation of PRL-3 expression levels we analysed expression of GAPDH. Oligonucleotides sequences are provided 
upon request. All of the experiments were performed in triplicate using two different retrotranscriptions. B: normalised PRL-3 
mRNA expression of DLD-1 cells cultured in conditioned media (CM) derived from fibroblasts and carcinoma-associated 
fibroblasts. We obtained matched fibroblasts cultures from fresh surgical specimens from one patient with colorectal carci-
noma with synchronous hepatic metastasis under the supervision of the Ethics Committee of the Hospital Universitari de Bel-
lvitge. We isolated normal colonic fibroblasts (NCF) from the normal colonic mucosa at least 5 cm from the surgical margin, 
carcinoma-associated fibroblasts (CAFpt) from the primary tumour and carcinoma-associated fibroblasts (CAFlm) from the 
synchronous metastasis. We also obtained foreskin fibroblasts from another patient. All tissues were minced into small frag-
ments and washed with Hanks Balanced Salt Solution (Gibco) and filtered with a 70 μm cell strainer (BD). Then fibroblasts and 
CAF's were cultured in Dulbecco's modified Eagle's F12 medium (Lonza), containing 10% fetal bovine serum (Gibco) and peni-
cillin/streptomycin. After five passages, cells in confluence were harvested and cultures were used to make CM. Thus, fibrob-
lasts or CAF's were grown to confluence in DMEMF12 containing 10% FBS. Then were washed twice in PBS and incubated for 
48 h in DMEMF12 without FBS. Next, fibroblasts/CAFs cultures were washed twice in PBS and incubated for 48 h in DMEMF12 
containing 10% FBS. CM was centrifuged 5 minutes at 3000 rpm and filtered in 22 μm units and stored at -80°C until use. 
Therefore, CM from activated myofibroblasts (CAFpt, CAFlm) produces a higher stimulation of mRNA PRL-3 than CM from 
normal colonic fibroblasts from the same patient. As a control we used DMEMF12 + 10% FBS. In all panels, error bars indicate 
standard deviation corresponding to three different experiments.
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mesenchymal cells could influence the behaviour of the
tumour population.
In this study we report modulation of PRL-3 expression in
CRC cell lines dependant on soluble factors released into
fibroblast conditioned media (CM). Moreover, we
describe an association between PRL-3 overexpression in
epithelial cells and desmoplastic reaction in human sam-
ples.
Findings
PRL-3 is overexpressed in different colorectal and 
pancreatic cell lines when cultured in conditioned media 
derived from carcinoma-associated fibroblasts from liver 
metastasis
We cultured a wide panel of colorectal and pancreatic cell
lines, derived from primary tumours and secondary sites
for 24 hours in their standard culture medium
(DMEMF12 + 10%FBS) or in conditioned medium
obtained from CAFs derived from a CRC liver metastasis.
CM was produced as follows: CAFs were grown to conflu-
ence and CM was harvested after 48 hours of culture, cen-
trifuged to remove cellular debris and filtered. PRL-3
mRNA expression was examined by real-time Q-PCR in
nine colorectal and two pancreatic cell lines. All colorectal
cell lines exhibited low levels of mRNA PRL-3 expression
when cultured in standard DMEMF12 medium plus
10%FBS. On the other hand, pancreatic cell lines dis-
played moderate levels. But interestingly, as shown in fig-
ure 1A, both cell lineages increased PRL-3 mRNA
expression when cultured in CM derived from CAFs, with
the highest fold change observed in DLD-1 cells (6.479
fold). We hypothesised that products released by the
stroma interact with receptors in the epithelial compart-
ment to induce PRL-3 overexpression. Since our colorectal
cell panel include almost all genetic backgrounds, this
cross-talk may be a common event in CRC.
CM from various fibroblasts lineages produces differential 
mRNA PRL-3 expression
We cultured DLD-1 cells for 24 h in CM, produced as
described above, obtained from Foreskin fibroblasts (FF)
and Normal colonic fibroblasts (NCF), metastasic pri-
mary tumour CAFs (CAFpt) and liver metastasis CAFs
(CAFlm) from the same patient (matched samples). As
shown in figure 1B, all CM induced significant (P < 0.05)
overexpression of mRNA PRL-3 measured by Q-PCR com-
pared with DMEMF12 control. Analysis of statistical sig-
nificance used the ANOVA test and Tukey post hoc.
Moreover, it is possible to put expression values in two
groups according to activated (CAFpt and CAFlm; approx-
imately 7 fold change in relation to control DMEMF12 +
10% FBS) or non-activated fibroblasts (FF and NCF;
approximately 3.5 fold change). Comparing non acti-
vated fibroblasts, normal colonic fibroblasts (from a
patient with colorectal cancer) and foreskin fibroblasts
exerts the same effect on mRNA PRL-3 expression (P =
0.983). Same trend is observed between CAFpt and
CAFlm (P = 0.514). Interestingly, comparing results from
matched samples, conditioned media from NCF induced
significantly (P = 0.036) lower levels of mRNA PRL-3 than
CM from activated fibroblasts of the same patient. Accord-
ingly, we conclude that CM obtained from CAFs more effi-
ciently induce the overexpression of phosphatase PRL-3
than non-activated fibroblasts. The high expression values
obtained with CAFpt are in agreement with a previous
report [8] demonstrating high mRNA PRL-3 expression in
primary Stage III tumours that developed distant metasta-
sis. As shown in figure 2, this results were confirmed at the
protein level in DLD-1 cells stimulated with CM from
CAFpt and CAflm, reaching the highest intensity in cells
cultured with CM CAFlm (figure 2E).
Immunostaining of PRL-3 (Abcam, Cambridge, UK) in DLD-1 cells cultured in DMEMF12 + 10% FBS (A), CM from foreskinfibroblasts (B), CM from norm l colonic f broblasts (C), CM ro  CAFs from a p imary tu our (D), CM from CAFs froml ver meta tas s (E)Figure 2
Immunostaining of PRL-3 (Abcam, Cambridge, UK) 
in DLD-1 cells cultured in DMEMF12 + 10% FBS (A), 
CM from foreskin fibroblasts (B), CM from normal 
colonic fibroblasts (C), CM from CAFs from a pri-
mary tumour (D), CM from CAFs from liver metas-
tasis (E). Briefly, cells were fixed 5 min. in ice cold 
methanol, washed in PBS and incubated for 1 hour in block-
ing buffer 1:5 in PBS (horse serum and goat serum, 1:1 v/v). 
Then, overnight incubation with rabbit polyclonal antibody 
against PRL-3 (Sigma Aldrich). After washing steps, 1 hour 
incubation with Goat anti rabbit IgG (H+L) FITC conjugated 
(Jackson).Page 3 of 7
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A: Immunohistochemistry (IHC) of alpha-Smooth muscle actin (α-SMA, prediluted mouse monoclonal anti-α SMA, Abcam, Cambridge, UK) in a Stage IIC c lorect l carcino a with high PRL-3 mRNA expressi n [8]Figure 3
A: Immunohistochemistry (IHC) of alpha-Smooth muscle actin (α-SMA, prediluted mouse monoclonal anti-α 
SMA, Abcam, Cambridge, UK) in a Stage IIIC colorectal carcinoma with high PRL-3 mRNA expression [8]. Rep-
resentative slide photography showing intense staining of stromal cells corresponding to CAFs. Briefly, mouse monoclonal anti-
α SMA antibody was diluted 1/3 in PBS and incubated for 1 hour at room temperature. After washing steps, reaction was visu-
alized using EnVision anti-mouse antibody system, and developed using DAB-Plus Kit (Dako, Copenhagen, Denmark). Slides 
were counterstained with Harry's modified hematoxylin. As a negative control, we used EnVision anti-mouse antibody system 
which displayed no reactivity against any antigen. Positive and negative controls were included in each assay. For IHC quantifi-
cation, we evaluated non-adjacent tumoral regions to the muscular layer to avoid confusing results. Expression was evaluated 
according to intensity (1 = -, undetectable or + light; 2 = ++, moderate; 3 = +++, intense staining) and percentage of stain (1 = 
< 10%; 2 = 10–50%; 3 = > 50%). A score containing the information for both parameters [(intensity +1) × percentage] was 
assigned, classifying staining as "low" or "high". B: Intense deposition of collagen fibrils in a high mRNA PRL-3 expression Stage 
IIIC colorectal carcinoma, using Masson trichrome staining (Sigma-Aldrich). To evaluate staining we considered the percentage 
of tissue occupied by collagen fibrils in relation to total tissue area in each slide without taking into account the muscular layer 
(< 5% absence; 5–15% slight; 15–50% moderate and > 50% intense deposition). C: Slight deposition of collagen fibrils in a Stage 
IIIC colorectal carcinoma with previously documented low levels of mRNA PRL-3 expression [8].
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Disease free survival Kaplan-Meier plots according to (A) alpha-smooth muscle actin (α-SMA) status and (B) Masson trichrome stainingFigure 4
Disease free survival Kaplan-Meier plots according to (A) alpha-smooth muscle actin (α-SMA) status and (B) 
Masson trichrome staining. 43 metastasic primary colorectal tumours (22 stage IIIB and 21 stage IIIC) were obtained from 
the Department of Pathology of the Hospital Universitari de Bellvitge. All patients underwent radical surgical resection and 
received chemotherapy adjuvant treatment. P-values correspond to Log rank test and were considered significant if P ≤ 0.05. 
All patients gave written consent to give tumour samples to Hospital Universitari de Bellvitge tumour bank, and the ethics 
committee of the hospital cleared the tumour harvesting and grafting protocols.
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of desmoplasia
These results, in combination with prior reports outlining
PRL-3 overexpression in hepatic metastases and metasta-
sic primary tumours [8,9] led to the hypothesis that PRL-
3 expression is induced by products secreted by surround-
ing activated fibroblasts adjacent to the tumour compart-
ment. We then evaluated the expression of smooth muscle
actin (α-SMA), and collagen deposition (Masson stain-
ing) in a subset of 43 metastasic primary tumours (22
stage IIIB and 21 stage IIIC) for which we had paraffin-
embedded tissue, from the entire 80 samples series where
we previously assessed PRL-3 mRNA expression [8]. The
evaluation was done by two blinded independent investi-
gators (XS and LP). In samples with high mRNA PRL-3
expression, 85.71% (18/21) of tumours displayed high
degree of infiltration of CAFs evaluated as the proportion
of mesenchymal cells stained with α-SMA antibody (Chi
square test, P = 0.029; Figure 3A). Moreover, the evalua-
tion of collagen deposition revealed a high degree of
fibrils in tumours with high mRNA PRL-3 expression,
accounting for 71.4% with intense deposition (Figure
3B), 19.04% for moderate and 9.52% for slight or absence
(Figure 3C)(Chi square test, P = 0.009). In addition,
binary logistic regression showed that both high expres-
sion of α-SMA and intense and moderate Masson staining
associate with tumour aggressiveness and were predictors
of distant metachronous metastasis in univariate analysis
(P = 0.05, OR 4.35, CI 0.99–19.12 for α-SMA; P = 0.024,
OR 6.92, CI 1.29–37.05 for collagen deposition). As
shown in figure 4, high expression of α-SMA and intense
deposition of collagen fibrils trend with worse prognosis,
although not reaching statistic significance probably due
to sample size.
Hence, tumours with high mRNA PRL-3 have a more
aggressive behaviour and high probability to relapse. As
high primary tumour PRL-3 expression is induced by stro-
mal factors, the abundance of myofibroblasts in cancer-
associated stroma may be a useful indicator of disease
recurrence after curative colorectal cancer surgery as sug-
gested by Tsujino T et al [10]. Notwithstanding, for prog-
nosis purposes is mandatory to validate the α-SMA
expression and collagen deposition in larger and consecu-
tive series in the adjuvant setting.
Crosstalk between tumour microenvironment and trans-
formed epithelial cells plays a central role in the fate of
malignant tumour cells by locally modifying signalling
pathways at the primary tumour site, enhancing the
migration and invasion of metastatic cells and, preparing
secondary organ sites for metastatic growth [11]. More
interestingly, genetic alterations in CAFs [12] and deregu-
lation of key pathways [13] may enhance the migration
and invasion through those crosstalk mechanisms. PRL-3
is key molecule involved in those processes of migration
and invasion, and has been involved in the natural out-
growth of metastatic capabilities of desmoplastic tumours
like colon, pancreas and breast. Here, we demonstrate that
elevated PRL-3 expression, observed in colorectal primary
tumours and distant secondary sites, is induced by prod-
ucts secreted by the surrounding activated stroma. Identi-
fication of those CAF-derived factors may inform on new
stroma-targeted therapies for desmoplastic tumours.
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